CytoDyn is a publicly traded biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses. CytoDyn s lead product candidate, PRO , has the potential to drive groundbreaking advancements in developing the next generation of HIV treatments.
Quote | CytoDyn Inc (OTCMKTS:CYDY)
Last: | $0.15085 |
---|---|
Change Percent: | -0.68% |
Open: | $0.147 |
Close: | $0.15085 |
High: | $0.1557 |
Low: | $0.14255 |
Volume: | 806,934 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
News | CytoDyn Inc (OTCMKTS:CYDY)
TAAT Global Alternatives Inc. (TOBAF) is expected to report for quarter end 2024-01-31 ABCO Energy (ABCE) is expected to report for quarter end 2023-12-31 GameSquare Holdings Inc. (GAME) is expected to report $-0.26 for Q1 2023 Skillsoft Corp. Class A (SKIL) is expected to report $-3....
QUADIENT S.A ADR (NPACY) is expected to report for quarter end 2024-01-31 Jeffs' Brands Ltd (JFBR) is expected to report for quarter end 2023-12-31 Avid Bioservices Inc. (CDMO) is expected to report $0.02 for Q3 2024 TAAT Global Alternatives Inc. (TOBAF) is expected to report for quar...
Message Board Posts | CytoDyn Inc (OTCMKTS:CYDY)
Subject | By | Source | When |
---|---|---|---|
dfwl28: "A causal role was recently attributed to inflammation in many malignant diseases, including | dfwl28 | investorshangout | 05/06/2023 2:14:07 PM |
Hulk767: reading these articles / reports reminds me of how great it will be to get coverage by a re | Hulk767 | investorshangout | 05/06/2023 2:14:00 PM |
dfwl28: "Tumor cells can hijack chemokine networks to support tumor progression. In this context, th | dfwl28 | investorshangout | 05/06/2023 1:42:49 PM |
seemingly-harmless: yes the billing code revelation took a good tug at my wallet also....if they wer | seemingly-harmless | investorshangout | 05/06/2023 1:25:50 AM |
AngryMan: All we can do is hope it is soon. ER thanks for keeping this board as a credible place. I | AngryMan | investorshangout | 05/05/2023 8:05:34 PM |
News, Short Squeeze, Breakout and More Instantly...
TAAT Global Alternatives Inc. (TOBAF) is expected to report for quarter end 2024-01-31 ABCO Energy (ABCE) is expected to report for quarter end 2023-12-31 GameSquare Holdings Inc. (GAME) is expected to report $-0.26 for Q1 2023 Skillsoft Corp. Class A (SKIL) is expected to report $-3....
QUADIENT S.A ADR (NPACY) is expected to report for quarter end 2024-01-31 Jeffs' Brands Ltd (JFBR) is expected to report for quarter end 2023-12-31 Avid Bioservices Inc. (CDMO) is expected to report $0.02 for Q3 2024 TAAT Global Alternatives Inc. (TOBAF) is expected to report for quar...
Webcast to Provide Company Update on March 5, 2024 VANCOUVER, Washington, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications...